## Renal Artery Stenosis (RAS) Overview
- **Definition**: Narrowing of the renal artery lumen; requires 50% reduction in vessel diameter to be significant.
- **Complications**: Ischaemic nephropathy, renal vascular hypertension (chronic reduction in GFR).

### Diagnosis
**Key Diagnostic Factors**:
- **Hypertension**:
  - Severe, progressive, or hard to control
  - No family history
- **Unexplained Kidney Dysfunction**
- **Sudden or Unexplained Recurrent Pulmonary Oedema**

**Strong Risk Factors**:
- Dyslipidaemia
- Smoking
- Diabetes

**Examination Findings**:
- Hypertension
- Abdominal Bruit

**Main Causes**:
1. **[[Atherosclerosis]]**:
   - Hypertension onset >55 years
   - History of coronary artery disease
   - History of peripheral vascular disease
2. **Fibromuscular Dysplasia**:
   - Hypertension onset <30 years 

**Severity of Stenosis**:
- Moderate: 50-70% reduction
- Severe: >70% reduction
- Total Occlusion: 100% reduction

### Investigations
**1st Line Investigations**:
- Serum Creatinine: Normal or elevated
- Serum Potassium: Hypokalaemia suggests RAS
- Urinalysis: Usually normal if diabetic nephropathy or hypertensive glomerulosclerosis absent
- Aldosterone-to-Renin Ratio: <20 excludes primary aldosteronism

**Imaging**:
- **1st Line**: Duplex Ultrasound
  - Criteria:
    - Renal artery to aorta peak systolic velocity ratio >3.5
    - Peak systolic velocity >200cm/sec with post-stenotic turbulence
    - End-diastolic velocity >150cm/sec
    - Renal resistive index >0.8
- **Follow-ups**:
  - Non-CKD: CT Angiography, MR Angiography, Captopril renal scan
  - CKD: Non-contrast MR angiography

**If inconclusive**: Invasive testing with conventional angiography (most sensitive and specific).

### Management (Prescribing)
- **Target BP**: <130/80mmHg
- **1st Line Medications**:
  - Captopril, Enalapril, Valsartan, Losartan
- **Secondary Options**:
  - Hydrochlorothiazide, Furosemide, Atenolol, Amlodipine, Nifedipine, Prazosin
- **Tertiary Options**:
  - Clonidine, Hydralazine, Methyldopa, Minoxidil

**[[Atherosclerosis]] Management**:
- **1st Line**: 
  - Antihypertensives, Statin (Atorvastatin, Fluvastatin, Lovastatin, Rosuvastatin, Simvastatin), Aspirin (70-300mg OD)
- **2nd Line**:
  - If stented: Clopidogrel (75mg OD)

**Fibromuscular Dysplasia Management**:
- **1st Line**:
  - Antihypertensives, Percutaneous renal artery balloon angioplasty
- **2nd Line**:
  - If stented: Aspirin + Clopidogrel (as above)

### Management (Non-Prescribing)
**Lifestyle Modifications**:
- Low-salt diet
- Weight reduction
- Smoking cessation
- Optimisation of glycaemic control

**Treatment Recommendations**:
- **Fibromuscular Dysplasia**: First-line treatment with percutaneous renal artery balloon angioplasty.
- **Renal Artery Stenting Considerations**:
  - Refractory hypertension with >3 antihypertensives
  - Progressive chronic kidney disease
  - Acute kidney injury on ACEi/ARB
  - Recurrent flash pulmonary oedema
  - Bilateral RAS
  - RAS in single functioning kidney

**Surgical Reconstruction**: 3rd line if major aortic reconstruction is indicated (e.g., AAA repair).

### References
- [BMJ Best Practice](https://bestpractice.bmj.com/topics/en-gb/435)